Studies of preparations of 111In-octreotide and 123I-methylene blue (MB) in the capacity of potential radiodiagnostic tools in the conditions in vitro and in vivo

The studies are devoted to affinity of preparations 111In-octreotide and 123I-methylene blue to cell lines of human neoplasms (small-celled lung cancer (P-69), mammary glands adenocarcinoma (MCF-7), pheochromocytoma (PC-12), melanoma (B-16), as well as its pharmacokinetics in small animals organisms, intact and with model pathology (perevite melanoma B-16). In in vitro conditions the 111In-octreotide accumulation kinetics in dependence of it accumulation level and type pf cell lines is determined. It is established, that at 111In-octreotide administration to female mice F1 with tumor B16, the preparation is relatively quickly moving out with urine, as well as hepatobiliary system. In 3 hours after the preparation administration ratios tumor/blood and tumor/muscle make up 3/1 and 4/1 relatively. It is shown. that 123I-MB accumulation in the pigmented melanoma in vitro achieves the maximum in 2 h after the preparation administration in culture medium, and in 3 h exceeds accumulation of preparation by non-pigmented cells (Chinese hamster's fibroblasts). During in vitro studies activity in perevite melanoma cells achieves 2-3%/g in 24 h. To the time the non-coupled with tumor activity is practically entirely moving out the organism. At present the indicated preparations proceed preclinical trial and expect permission of clinic trials